骶管联合用药治疗慢性盆腔炎临床观察

Clinical observation on the treatment of chronic pelvic inflammation by combination of several drugs at transacral

目的 探讨骶管联合用药治疗慢性盆腔炎的价值。方法 77例慢性盆腔炎病人分三组 ,A组含 0 5 %利多卡因 ,B组含 1%利多卡因 ,A、B组内均含维生素B12 0 5mg、妥布霉素 4万U ,第 1次注射加用地塞米松 5mg ,第 2次 2 5mg ,后不再加用 ;C组为单纯生理盐水 ,隔 2天 1次 ,每 3次为 1个疗程。 结果 A、B组间治愈率无差异 (P >0 0 5 ) ,A、B组总治愈率为 94 0 % ,与C组比较差异有非常显著意义 (P <0 0 1)。结论 骶管联合用药治疗慢性盆腔炎 ,治愈率达 94 0 % ,副作用少。 0 5

Objective To study the value of combined use of several medicines at transacral in the treatment of inflammation .Methods 77 femal patients with chronic pelvic inflammation were divided into three groups.0.5% Lidocaine, VitB 12 0.5mg and tobramycinum 4000U were used in group B, group A and B were 1st injected with dexamethasone 5mg,the 2nd time 2.5mg,and then no more. The patients in group C were injected with only normal saline solution. The treatment was given q2d.Every three times were treatment course.Results The cure rate between group A and B demonstrated no difference(P>0.05),the total cure rate in group A and B was 94.0%;there was significant difference if compared with group C(P<0.01).Conclusion The cure rate of the reported management method is 94.0%,with little side effects,and the dosage of 0.5% lidocaine is more reasonable and safer.